News
June 11, 2025 | Company
Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI
June 02, 2025 | FDA
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality
May 28, 2025 | FDA
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System
May 15, 2025 |
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference
April 29, 2025 |
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025
April 15, 2025 | Company
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices
March 04, 2025 | Company
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
February 11, 2025 | Company
Hyperfine Announces $6.0 Million Registered Direct Offering
February 06, 2025 | Publications
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference
December 17, 2024 | Company
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
December 05, 2024 | Publications
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
December 03, 2024 | Company
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals
November 21, 2024 | Company
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body
November 19, 2024 | Publications
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings
November 07, 2024 | Company
Hyperfine Announces European Launch with CE Approval
October 31, 2024 | Publications
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
October 01, 2024 | Publications
Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation
September 23, 2024 | Publications
Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care
September 11, 2024 | Collaboration
Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System
July 30, 2024 | Publications
Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients
July 17, 2024 | FDA
Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images
July 15, 2024 | Publications
Portable MRI as a Tissue Clock for Acute Ischemic Stroke: Multi-Site Study to be Published in August 2024 Edition of Annals of Neurology Shows the Value of the Ultra-Low-Field Swoop® Portable MR Imaging® System in Acute Stroke Diagnosis
July 10, 2024 | Company
Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
June 25, 2024 | Publications
Clinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer’s Association International Conference
May 28, 2024 | Company
Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India
May 22, 2024 | Company
Hyperfine, Inc. Celebrates ASNR 2024
May 10, 2024 | Company
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets
April 23, 2024 | Publications
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
April 17, 2024 | Collaboration
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
March 12, 2024 | Collaboration
Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal
February 21, 2024 | Collaboration
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
February 01, 2024 | Publications
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
January 09, 2024 | FDA
Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use
November 20, 2023 | Publications
Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023
November 02, 2023 | Publications
Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients
October 10, 2023 | Company
Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives
October 09, 2023 | FDA
Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences
August 09, 2023 | Collaboration
Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System
July 18, 2023 | Company
Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer
July 11, 2023 | Collaboration
Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care
June 08, 2023 | Collaboration
Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR Education
May 18, 2023 | Collaboration
Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income Countries
February 28, 2023 | FDA
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
February 21, 2023 | Company
Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations
February 13, 2023 | FDA
Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System
February 09, 2023 | Company
Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a Thrombectomy
February 08, 2023 | Company
Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer
February 06, 2023 | Company
Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage at ISMRM with Twelve Abstract Inclusions
October 06, 2022 | Company
Hyperfine Names Maria Sainz President and Chief Executive Officer
July 26, 2022 | Partner News
Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm
July 14, 2022 | Company
Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Sequence with Faster Scan Time to Benefit Pediatric Patients
June 21, 2022 | FDA
Hyperfine Receives FDA Clearance for Two New Imaging Sequences
June 14, 2022 | Company
Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification
February 16, 2022 | Collaboration
Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities
February 08, 2022 | Company
Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director
January 19, 2022 | Collaboration
M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering
December 22, 2021 | Company
Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker “HYPR” on the Nasdaq Global Market
December 13, 2021 | Company
Hyperfine Appoints New Board of Directors
December 09, 2021 | Company
Hyperfine Announces Expansion into Canadian Market with Medical Device License Issued by Health Canada
December 07, 2021 | Collaboration
Hyperfine Partners With Madonna’s Charitable Organization, Raising Malawi, to Increase Access to High Quality Healthcare for Children
November 29, 2021 | FDA
Hyperfine Receives FDA Clearance for Deep Learning Portable MRI, Defining the Future of Life-Saving Diagnostics
November 29, 2021 | Company
Hyperfine, Liminal Sciences, and HealthCor Catalio Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
November 02, 2021 | Collaboration
Hyperfine Announces Receipt of Additional $3.3 Million Grant to Improve Access to Neonatal and Pediatric Brain Imaging in Low-Resource Settings Globally
October 28, 2021 | Company
Hyperfine Appoints Scott White as Chief Commercial Officer
October 14, 2021 | Company
Hyperfine Announces Formation of Medical Advisory Board
September 28, 2021 | Company
Hyperfine Announces Plans for Global Expansion Starting with Launches in the United Kingdom and Pakistan
September 13, 2021 | Company
Hyperfine Announces Analyst and Investor Meeting on September 27
August 31, 2021 | Company
Hyperfine Appoints Kyla Pavlina, J.D., as Chief People Officer
August 25, 2021 | Publications
Hyperfine’s Portable MRI System Demonstrates High Accuracy for Detection of Brain Hemorrhage in Study Published in Nature Communications
August 23, 2021 | Company
Hyperfine Announces Appointment of Alok Gupta as Chief Financial Officer
August 12, 2021 | Recognition
Fast Company Recognizes Jonathan M. Rothberg in its “Most Creative People in Business” List
July 08, 2021 | Company
Hyperfine, Inc., creator of the first FDA-cleared portable MRI device, and Liminal Sciences, Inc. to be listed on Nasdaq through a business combination with HealthCor Catalio Acquisition Corp.
June 30, 2021 | Company
Hyperfine Names Paykel and Teisseyre to Executive Leadership Positions
June 15, 2021 | Company
Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman
June 08, 2021 | Company